Correction of Stock Option Grant: Exercise Price Lowered and Shares Increased
-
Correction filing: Amendment to stock option grant report (original filed 2019.06.14, correction 2026.05.14)
-
Grantees: decreased from 5 to 3
-
Shares granted: increased from 108,000 to 202,000 (+87%)
-
Exercise price: significantly lowered from 40,600 won to 11,600 won (adjusted due to capital increase and stock dividend)
-
Total outstanding options after this grant: increased from 1,941,396 to 4,092,568 shares
-
Fair value: slightly decreased from 35,964 won to 34,972 won
-
Exercise period: 2021.06.15 ~ 2028.06.14
-
Valuation model: Binomial model, key assumptions: risk-free rate 1.59%, expected volatility 77.84%
KOSDAQ Filing Information
-
Filing: [Correction of Description] Report on Grant of Stock Options
-
Company: Genome & (314130)
-
Submission: Genome & Company
-
Receipt: 05-14-2026